Proteinuria: all 328 studies
Page 3 of 4. Open to participants first (44), then studies with results posted, then the rest; newest registration first within each.
- RAS Quantification in Patients With Aliskiren or CandesartanCompletedNCT01827202Phase 4
- Urine-plasminogen as a Predictor for Development Of Preeclampsia in Pregnant Women With Type 1 Diabetes MellitusCompletedNCT01821053
- Oral Calcitriol for Reduction of Mild Proteinuria in Patients With CKDStatus unknownNCT01820832Phase 4
- Paricalcitol on Albuminuria, Inflammation and Fibrosis on Proteinuric Chronic Renal Diseases (PALIFE Study)TerminatedNCT01820078Phase 4
- Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 DiabetesTerminatedNCT01804777Early Phase 1
- Minocycline and Proteinuria in Diabetic NephropathyStatus unknownNCT01779089Not applicable
- The Effects of Weight Reduction in IgA NephropathyStatus unknownNCT01773382Not applicable
- Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous NephropathyWithdrawnNCT01762852Phase 2
- Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013)Status unknownNCT01760096Phase 2
- The Effects of Omega-3 Fatty Acids in Renal TransplantationCompletedNCT01744067Phase 4
- Effect of Calcium Channel Blocker on the Serum Fibrobalst Growth Factor-23 (FGF-23) Levels in Type-2 Diabetic Patients With Proteinuria PurposeCompletedNCT01738945Phase 4
- FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric PatientsCompletedNCT01703234Phase 4
- Oral Paricalcitol in Renal Transplant Recipients for Reducing AlbuminuriaCompletedNCT01694160Phase 3
- Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal HemoglobinuriaStatus unknownNCT01642979Phase 2
- MARCH Renal SubstudyCompletedNCT01637259Phase 4
- Random Urine Protein-creatinin Ratio to Predict Magnitude of ProteinuriaStatus unknownNCT01623791
- Factors of Steroid Dependency in Idiopathic Nephrotic SyndromeCompletedNCT01609426
- Human Urine Sample Collection for Alport Nephropathy Biomarker StudiesTerminatedNCT01602835
- Urinary Protein/Creatinine Ratio in a Single Urine Sample Versus 24-hour Proteinuria in Patients With Multiple MyelomaCompletedNCT01572857
- Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy DeteriorationStatus unknownNCT01566006Not applicable
- The Effect of Various Types of the Renin-angiotensin-aldosterone System Blockade on ProteinuriaCompletedNCT01541267Phase 4
- Anti-proteinuric Effect of Calcitriol in Non-diabetic Kidney Disease PatientsStatus unknownNCT01512862Phase 4
- Early Diagnosis of Postoperative Acute Renal Failure-using Biomarker to Predict Outcome of Cardiac Surgery Associated Acute Kidney InjuryStatus unknownNCT01503710
- A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine.CompletedNCT01464320Phase 1
- Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Transplant RecipientsCompletedNCT01436747Phase 3
- Effects of Vitamin D on Renal Blood Flow, Proteinuria and Inflammation in Patients With Chronic Kidney DiseaseWithdrawnNCT01426724Not applicable
- Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With AtrasentanCompletedNCT01424319Phase 2
- Bariatric Surgery and the KidneyCompletedNCT01410994
- Removal of Anti-Angiogenic Proteins in Preeclampsia Before DeliveryCompletedNCT01404910Not applicable
- Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 DiabetesCompletedNCT01393808Phase 2
- Steroids and Azathioprine in Advanced IgANCompletedNCT01392833Phase 3
- Steroid Treatment of Idiopathic Nephrotic SyndromeCompletedNCT01386957
- Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) InhibitorCompletedNCT01356849Phase 2
- A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis PatientsTerminatedNCT01316133Phase 4
- An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus NephritisCompletedNCT01273389Phase 2
- Safety And Efficacy Of Spirinolactone Plus Hydroflumethiazide In The Treatment Of Filipino Patients With HypertensionWithdrawnNCT01260857
- Registry for Patients With Wilms' Tumor Suppressor Gene 1 (WT1) Mutation Associated DiseasesCompletedNCT01252901
- Impedance Cardiographic (ICG) Assessment of Pregnant Women With Severe Hypertension to Assess Impact of Standard TherapyCompletedNCT01248169
- Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled TrialCompletedNCT01225445Phase 3
- Influence of Aliskiren on ProteinuriaCompletedNCT01219413Phase 4
- Velcade for Proliferative Lupus NephritisWithdrawnNCT01169857Phase 4
- Inflammatory and Immune Profiling of Kidney Tissue Obtained From Patients With Newly Diagnosed Kidney DiseaseCompletedNCT01156428
- Effects of an Exercise Program in Patients With Hypertensive Chronic Kidney DiseaseStatus unknownNCT01155128Phase 4
- Treatment for HBV-MN Patients in Chinese: An Open Parallel Controlled TrialStatus unknownNCT01152060
- Aliskiren Combined With Losartan in Proteinuric, Non-diabetic Chronic Kidney DiseaseCompletedNCT01150201Phase 4
- Role of Donor Genetics and Recipient Genetics in Kidney Transplant OutcomesCompletedNCT01143532
- Reno- and Vascular Protective Effect of a Vitamin-D-analogue in Moderate to Severe Chronic Kidney DiseaseCompletedNCT01136564Phase 2
- Dextromethorphan and Silymarin in Chronic Kidney Disease (CKD) PatientsStatus unknownNCT01091324Phase 3
- Effect of Turmeric on Diabetic NephropathyCompletedNCT01015937Not applicable
- The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous NephropathyCompletedNCT00983034Not applicable
- Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric PatientsTerminatedNCT00961207Phase 4
- Safety of Add on Aliskiren to Angiotensin Converting Enzyme Inhibitor (ACEI) and Angiotensin I Receptor Blocker (ARB) Treatment in Type 2 Diabetes With NephropathyStatus unknownNCT00949351Phase 4
- Prospective Study of TW in the Treatment of LN Type V With Gross ProteinuriaCompletedNCT00935389Not applicable
- Aliskiren for Proteinuric IgAN Despite Angiotensin BlockadeCompletedNCT00922311Phase 4
- The Effects of Renin Angiotensin System Blockage (RAS), Calcium Channel Blocker and Combined Drugs on TWEAK, PTX3 and FMD Levels in Diabetic Proteinuric Patients With HypertensionCompletedNCT00921570Phase 4
- A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System InhibitorsCompletedNCT00920764Phase 2
- N-Acetylcysteine and Milk Thistle for Treatment of Diabetic NephropathyCompletedNCT00915200Phase 2
- Study of Prevalence of Proteinuria, Urinary Tract Infection or Hematuria in AthletesStatus unknownNCT00912834
- Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With ProteinuriaCompletedNCT00893425Phase 4
- Aliskiren for Immunoglobulin A (IgA) NephropathyCompletedNCT00870493Phase 3
- Predicitve Use of Spot Urine Protein/Creatinine Ratios in PreeclampsiaStatus unknownNCT00870428
- Mycophenolate Mofetil for IgA NephropathyCompletedNCT00863252Phase 4
- Ezetimibe/Simvastatin Combination in Proteinuric NephropathyStatus unknownNCT00861731Phase 4
- The Change of Urinary Angiotensinogen Excretion After Valsartan Treatment in Patients With Persistent ProteinuriaStatus unknownNCT00858299Phase 4
- Safety Study of of Intravenous CCL2-LPM in Patients With IgA NephropathyTerminatedNCT00856674Phase 1
- Evaluation of Protein in the Urine in Patients Receiving BevacizumabCompletedNCT00849394
- Sitaxsentan in Proteinuric Chronic Kidney DiseaseCompletedNCT00817037Phase 2
- Renal Function in Adults With Congenital Heart Disease.WithdrawnNCT00807274
- Prednisone Plus Tripterygium Wilfordii Treatment of Adult Patients With Idiopathic Focal Segmental GlomerulosclerosisCompletedNCT00801463Not applicable
- "Steroids and Azathioprine Versus Steroids Alone in IgAN"CompletedNCT00755859Phase 4
- Phase 1 Study of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic NephropathyCompletedNCT00754143Phase 1
- How Does the Diabetes Drug, Pioglitazone, Reduce Protein Loss in the Urine?Status unknownNCT00749047Phase 4
- Endothelin Receptor Antagonism in Proteinuric NephropathyCompletedNCT00722215Phase 1
- Adalat XL vs Diltiazem on Proteinuria and Blood Pressure in Hypertensive Diabetic PatientsWithdrawnNCT00713011Phase 3
- Pharmacodynamic Effects of Anti-Vascular Endothelial Growth Factor Therapy in Patients With Advanced MalignanciesTerminatedNCT00698659
- The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With ProteinuriaCompletedNCT00674596Phase 4
- Assessment of the Effect of Captopril Versus Combination of Captopril and Pentoxifylline on Reducing Proteinuria in Type 2 Diabetic NephropathyCompletedNCT00663949Phase 2/3
- Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes NephropathyStatus unknownNCT00655330Not applicable
- Comparison of Catheterized and Clean Catch Urine Specimens for Protein/Creatinine Ratio in Preeclampsia EvaluationCompletedNCT00654771
- Optimalization of Nephroprotection Using N-AcetylcysteineCompletedNCT00572663Not applicable
- Optimalization of Nephroprotection Using Atorvastatin (Sortis)CompletedNCT00572312Not applicable
- Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3Status unknownNCT00565396Not applicable
- Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic NephropathyCompletedNCT00556465Phase 2/3
- Rituximab Treatment of Focal Segmental GlomerulosclerosisWithdrawnNCT00550342Phase 2
- To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes MellitusCompletedNCT00550095Phase 4
- Sympathetic Overactivity in Essential HypertensionWithdrawnNCT00541619
- Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone SystemCompletedNCT00528385Not applicable
- Evaluation of Albuminuria HIV-Infected PatientsCompletedNCT00524992
- To Compare the Efficacy and Safety of Tripterygium (TW) Versus Valsartan in the Diabetic Nephropathy (DN)CompletedNCT00518362Not applicable
- To Compare the Efficacy and Safety of Tripterygium Wilfordii (TW) Versus Valsartan in the Membranous Nephropathy (MN)CompletedNCT00518219Phase 4
- The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent ProteinuriaWithdrawnNCT00508898Phase 4
- Influence of Pioglitazone for Renal Transplant Function in DiabeticsCompletedNCT00507494Phase 3
- Effect of N-Acetylcysteine (NAC) on Creatinine in Chronic Kidney DiseaseCompletedNCT00506506Phase 3
- Spironolactone for Reducing Proteinuria in Diabetic NephropathyCompletedNCT00498537Not applicable
- Use of Mucomyst to Ameliorate Oxidant Stress in Diabetics With ProteinuriaCompletedNCT00493727Not applicable
- Statins and the Urinary ProteomeCompletedNCT00464503Not applicable
- Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong KongTerminatedNCT00462202Phase 3
- The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) StudyCompletedNCT00446862
- Inhibition of Aldosterone in Patients With Chronic Renal DiseaseCompletedNCT00430924Phase 4
- HSP-glomerulonephritis Trial: MP vs CyACompletedNCT00425724Phase 4